PMID: 9182676Jun 16, 1997Paper

A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction

The Journal of Experimental Medicine
E CarboneS Zappacosta

Abstract

NK recognition is regulated by a delicate balance between positive signals initiating their effector functions, and inhibitory signals preventing them from proceeding to cytolysis. Knowledge of the molecules responsible for positive signaling in NK cells is currently limited. We demonstrate that IL-2-activated human NK cells can express CD40 ligand (CD40L) and that recognition of CD40 on target cells can provide an activation pathway for such human NK cells. CD40-transfected P815 cells were killed by NK cell lines expressing CD40L, clones and PBL-derived NK cells cultured for 18 h in the presence of IL-2, but not by CD40L-negative fresh NK cells. Cross-linking of CD40L on IL-2-activated NK cells induced redirected cytolysis of CD40-negative but Fc receptor-expressing P815 cells. The sensitivity of human TAP-deficient T2 cells could be blocked by anti-CD40 antibodies as well as by reconstitution of TAP/MHC class I expression, indicating that the CD40-dependent pathway for NK activation can be downregulated, at least in part, by MHC class I molecules on the target cells. NK cell recognition of CD40 may be important in immunoregulation as well as in immune responses against B cell malignancies.

References

Jul 1, 1990·Tissue Antigens·E A Clark
Feb 1, 1991·Current Opinion in Immunology·B Perussia
Jul 1, 1990·Immunology Today·H G Ljunggren, K Kärre
Jun 1, 1989·The Journal of Experimental Medicine·F SchrieverL M Nadler
Dec 1, 1988·The Journal of Experimental Medicine·E CicconeL Moretta
Jul 1, 1986·The Journal of Experimental Medicine·R E SchmidtJ Ritz
Nov 16, 1995·Nature·J E Gumperz, P Parham
Nov 1, 1993·Immunology Today·R E CallardM K Spriggs
Feb 1, 1994·Proceedings of the National Academy of Sciences of the United States of America·M FarringtonH D Ochs
Jan 1, 1994·Annual Review of Immunology·J BanchereauS Saeland
Nov 1, 1995·The Journal of Experimental Medicine·T M FoyR J Noelle
Mar 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·R FuleihanR S Geha
Aug 1, 1993·The Journal of Experimental Medicine·M R AldersonM K Spriggs
Mar 1, 1995·European Journal of Immunology·J F GauchatD Aldebert
Jul 1, 1994·International Immunology·P MombaertsA K Bhan
Mar 1, 1996·European Journal of Immunology·E CarboneS Zappacosta
Feb 1, 1996·European Journal of Immunology·C Döhring, M Colonna
Jan 1, 1996·Annual Review of Immunology·T M FoyR J Noelle
Feb 1, 1996·Immunology Today·L L Lanier, J H Phillips
Sep 1, 1996·The Journal of Experimental Medicine·Y GuoY Liu

❮ Previous
Next ❯

Citations

Dec 22, 1999·European Journal of Immunology·E CarboneS Zappacosta
Aug 24, 2000·International Journal of Cancer. Journal International Du Cancer·A R ZlottaK Huygen
May 16, 2003·Cellular Immunology·Rossella SartoriusPiergiuseppe De Berardinis
Oct 26, 1999·Immunology Today·R T CostelloD Olive
Feb 5, 2000·Human Immunology·M Valés-GómezJ Strominger
Dec 31, 2002·Microbes and Infection·Jordan S Orange
Oct 31, 2002·Nature Immunology·Hung T Khong, Nicholas P Restifo
Sep 13, 2005·Nature Medicine·Joshua N BeilkeRonald G Gill
Aug 8, 2001·Clinical and Experimental Dermatology·S R SinghR A Swerlick
Feb 6, 2002·The Journal of Experimental Medicine·Franca GerosaGiorgio Trinchieri
Jul 17, 2001·Journal of Hematotherapy & Stem Cell Research·G MakiY K Tam
Dec 23, 2003·Transplantation·Dirk Homann, Matthias G von Herrath
Nov 26, 2013·The Cancer Journal·Tomasz MajWeiping Zou
Sep 9, 2005·Clinical and Diagnostic Laboratory Immunology·Olga Atochina, Donald Harn
Nov 1, 2001·Clinical and Diagnostic Laboratory Immunology·M R O'GormanR Yogev
May 23, 1998·Annual Review of Immunology·I S Grewal, R A Flavell
May 23, 1998·Annual Review of Immunology·L L Lanier
Mar 18, 2011·Journal of Innate Immunity·Theresa PlackeHelmut Rainer Salih
May 13, 1999·Proceedings of the National Academy of Sciences of the United States of America·O MandelboimJ L Strominger
Sep 18, 2002·Immunological Reviews·María C MontoyaFrancisco Sánchez-Madrid
Dec 2, 1999·Journal of Neuroimmunology·N Abdel-HaqW D Lyman
May 13, 2010·Journal of Biomedical Optics·Gobind DasEnzo Di Fabrizio
Oct 24, 2000·Leukemia & Lymphoma·E J Schattner
Mar 29, 2003·Expert Opinion on Biological Therapy·Sherif S FaragMichael A Caligiuri
May 15, 2007·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·F CognasseO Garraud
Oct 27, 2015·Frontiers in Immunology·Michael AllenVishwanath Venketaraman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.